Product Information
NITAZOXANIDE 500 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $82.1970 per EA under NDC 64980052660. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Nov 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980052660
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITAZOXANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213820FDA Approved
11/27/2020
TE Code
AB
On Market Since
11/27/2020
Pharmacological Classes
Price Statistics
The NADAC for NITAZOXANIDE 500 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 16.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $82.1970 per EA |
|---|---|
| All-time high | $109.8033 (Aug 13, 2025) |
| All-time low | $82.1970 (Sep 23, 2026) |
| 52-week high | $96.7309 |
| 52-week low | $82.1970 |
| Median price | $89.2712 |
| Average price | $93.9989 |
| Largest weekly change | -14.2% (May 22, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nitazoxanide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiprotozoal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITAZOXANIDE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NITAZOXANIDE 500 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $82.1970 per EA (NDC 64980052660), effective Sep 30, 2026.
How has the price of NITAZOXANIDE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for NITAZOXANIDE 500 MG TABLET has declined 16.2%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for NITAZOXANIDE 500 MG TABLET?
Since Apr 17, 2024, the NADAC for NITAZOXANIDE 500 MG TABLET has ranged from a low of $82.1970 (Sep 23, 2026) to a high of $109.8033 (Aug 13, 2025), with a median of $89.2712 per EA.
Are there cheaper alternatives to NITAZOXANIDE 500 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NITAZOXANIDE 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NITAZOXANIDE 500 MG TABLET?
NITAZOXANIDE 500 MG TABLET (NDC 64980052660) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.